Centrient Hits Milestone On Antimicrobial Resistance

Semi-Synthetic Penicillin APIs Reach Target

Bacterial_Culture
AMR "poses a major threat to public health as well as business continuity," Centrient said • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Strategy

More from Business